지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수0
Ⅰ. 서 론 ··························································································································11. 연구 필요성 ····························································································································12. 연구 목적 ·······························································································································43. 연구 제한점 ····························································································································44. 용어 정의 및 약어 ·················································································································5Ⅱ. 연구방법 ······················································································································81. 연구대상 ·································································································································82. 연구절차 ·································································································································93. 측정도구 ·······························································································································104. 측정항목 및 방법 ················································································································115. 수중복합 운동프로그램 ·······································································································136. 자료처리 ·······························································································································15Ⅲ. 연구결과 ····················································································································161. 혈중지질 ·······························································································································172. 동맥경화지수 ························································································································233. Amyloid-beta(1-42) ···········································································································29Ⅳ. 논 의 ························································································································321. 혈중지질 ·······························································································································322. 동맥경화지수 ························································································································343. Amyloid-beta(1-42) ···········································································································36Ⅴ. 결 론 ························································································································38참고 문헌 ·························································································································40Abstract ··························································································································50
0